MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,735 Approvals
Showing 1541 to 1560 of 1,735 approvalsPage 78 of 87

Erbitux

Authorisation: Jun 29, 2004

TachoSil

Authorisation: Jun 8, 2004

Levemir

Authorisation: Jun 1, 2004

Dukoral

Authorisation: Apr 28, 2004

Lysodren

Authorisation: Apr 28, 2004

Velcade

Authorisation: Apr 26, 2004

Litak

Authorisation: Apr 14, 2004

Faslodex

Authorisation: Mar 9, 2004

Advate

Authorisation: Mar 2, 2004

Reyataz

Authorisation: Mar 1, 2004

Bonviva

Authorisation: Feb 23, 2004

Zevalin

Authorisation: Jan 16, 2004

Emend

Authorisation: Nov 11, 2003

Emtriva

Authorisation: Oct 24, 2003

Stalevo

Authorisation: Oct 17, 2003

Ventavis

Authorisation: Sep 15, 2003

Humira

Authorisation: Sep 8, 2003

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.